Learning objectives: Describe the clinical features of DADA2 and VEXASsyndrome.
Explain the difference between genotype-first approaches and phenotype-driven strategies for disease gene discovery.
Tuesday, December 8, 2020 - 12:00pm to 1:00pm
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Daniel L. Kastner, MD, PhD